Canopy Growth (CGC) Cash from Discontinued Operations (2022 - 2024)
Canopy Growth (CGC) posted Cash from Discontinued Operations of 297587.4 for Q1 2024, down 47.99% sequentially from 572203.18 in Q4 2023, and up 100.91% YoY from 148118.14 in Q2 2023.
Canopy Growth (CGC) Cash from Discontinued Operations (2022 - 2024) Analysis & Trends
Canopy Growth has reported Cash from Discontinued Operations for 3 years, with the latest figure at 297587.4 in Q1 2024.
- Quarterly Cash from Discontinued Operations rose 100.91% year-over-year to 297587.4 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 39876575.24 (changed N/A YoY) and the FY2024 annual result came in at 39724577.91, up 67.08% from the prior year.
- Cash from Discontinued Operations slipped to 297587.4 in Q1 2024 per CGC's latest filing, from 572203.18 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 572203.18 in Q4 2023 and troughed at 49240487.81 in Q4 2022.
- A 3-year average of 20290105.26 and a median of 20373182.91 in 2023 frame the typical range for Cash from Discontinued Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Discontinued Operations soared 101.16% in 2023, then jumped 100.91% in 2024.
- Over 3 years, Cash from Discontinued Operations stood at 49240487.81 in 2022, then soared by 101.16% to 572203.18 in 2023, then sank by 47.99% to 297587.4 in 2024.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 297587.4, 572203.18, and 9142869.77 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Canopy Growth | 434.93 Mn | 187.92 Mn | 16.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 297,587.40 |
| Mar 31, 2024 | 297,587.40 |
| Dec 31, 2023 | 572,203.18 |
| Dec 31, 2023 | 572,203.18 |
| Sep 30, 2023 | -9.14 Mn |
| Sep 30, 2023 | -9.14 Mn |
| Jun 30, 2023 | -31.60 Mn |
| Jun 30, 2023 | -31.60 Mn |
| Mar 31, 2023 | -32.62 Mn |
| Mar 31, 2023 | -32.62 Mn |
| Dec 31, 2022 | -49.24 Mn |
| Dec 31, 2022 | -49.24 Mn |